International Journal of Drug Policy
Volume 18, Issue 2 , Pages 75-83, March 2007

Strengthening drug policy and practice through ethics engagement: An old challenge for a new harm reduction

  • Kevin S. Irwin

      Affiliations

    • Yale School of Public Health, Center for Interdisciplinary Research on AIDS, Suite 1B, Room 111, 40 Temple St., New Haven, CT 06510, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 203 764 4338; fax: +1 203 764 4353.
  • ,
  • Craig L. Fry

      Affiliations

    • Turning Point Alcohol and Drug Centre Inc., and Department of Public Health, University of Melbourne, Australia

Received 3 November 2006; received in revised form 1 December 2006; accepted 5 December 2006.

Abstract 

Harm reduction proponents aim to identify and support policies and programmes that moderate or decrease the deleterious consequences of illicit drug use. While harm reduction is clearly a value-based response to drugs, for many, ‘ethics’ merely represent institutional research and professional practice regulations to be satisfied, subjective moral claims, or philosophy that is too abstract to offer tangible benefits in keeping with the pragmatism of harm reduction. In this paper we revisit the relationship between harm reduction and ethics, reframe ethics as a pragmatic concern for all of harm reduction, and argue that greater attention to the actual values and beliefs underpinning harm reduction can help to enhance policy, practice and research outcomes. Examples are given of early progress in this area to illustrate possible features of ethics engagement in harm reduction, and existing ethics materials are highlighted as suitable supporting resources for applied ethical decision-making in this field.

Keywords: Ethics, Harm reduction, Policy, Drugs, Research

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(06)00245-3

doi:10.1016/j.drugpo.2006.12.002

International Journal of Drug Policy
Volume 18, Issue 2 , Pages 75-83, March 2007